Skip to main content
. 2013 Dec 3;8(12):e82396. doi: 10.1371/journal.pone.0082396

Figure 7. Enumeration of F4/80+ TAM following orlistat administration to tumor-bearing host.

Figure 7

Peritoneal exudates cells obtained from control (a) and orlistat administered (b) tumor-bearing hosts were analysed for the number of TAM by flow cytometry using FITC conjugated antibody against macrophage marker F4/80. Data shown is from a representative experiment out of three independent experiments done in triplicate with similar results.